Children's Health: Obesity at a young age: Are weight loss injections the solution?
In some children with extreme obesity, the usual therapy approaches have no success. GLP-1 medications can help them curb hunger, but the long-term consequences are unclear.
About 2 million children and adolescents in Germany are overweight, with approximately 800,000 suffering from the chronic condition of obesity. Two GLP-1 medications, Semaglutid and Liraglutid, are approved for use in children and adolescents with obesity, with Semaglutid approved for use from age 12 and Liraglutid from age 6 under certain conditions.
The German medical guidelines have been updated to consider medication therapy for minors with extreme obesity in specialized centers. According to data from the KiGGS study, 15% of children and adolescents in Germany have overweight and 6% have obesity, with around 200,000 having extreme obesity, although these numbers may have increased since the data was collected between 2015 and 2017.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.